NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
TRIOSTAT (liothyronine sodium) by Pfizer is synthesis. First approved in 1991.
Drug data last refreshed 12h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRIOSTAT is a synthetic liothyronine sodium (T3) injection approved by Pfizer for thyroid hormone replacement therapy. It acts as a direct thyroid hormone agonist, binding to nuclear thyroid receptors to activate gene transcription and increase cellular metabolism. This injectable formulation is used in acute hypothyroidism and situations requiring rapid thyroid hormone supplementation.
LOE Approaching
This legacy injectable product faces moderate competitive pressure (30) with declining commercial momentum, suggesting smaller teams and defensive positioning rather than growth-focused hiring.
Mechanism of Action
synthesis. Triiodothyronine (T3) and L-thyroxine (T4) diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins. The physiological actions of thyroid…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TRIOSTAT offers exposure to legacy product management, specialty pharmacy channels, and defensive commercial strategy in a declining market segment. Career value is highest for professionals interested in niche acute-care therapeutics, hospital formulary advocacy, and transition planning ahead of generic competition.
Brand Manager
Worked on TRIOSTAT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.